In Featured, News by Ged Kenslea
December 30, 2020
On Wednesday, the HHS Office of the General Counsel released an advisory opinion concluding that drug manufacturers are required to deliver discounts under the 340B Drug Pricing Program on covered outpatient drugs when contract pharmacies are acting as agents of 340B covered entities
they planned to refuse to provide certain drugs at the legally required ‘340B price’
as required by section 340B of the U.S. Public Health Services Act
WASHINGTON (December 30, 2020) AIDS Healthcare Foundation (AHF) welcomed and praised an advisory opinion issued earlier today by the Office of the General Counsel for the United States Health and Human Services Department (HHS) which concluded that drug manufacturers are required to deliver discounts under the 340B Drug Pricing Program on covered outpatient drugs when contract pharmacies are acting as agents of 340B covered entities. (HHS press release)
AHF to Protest Amgen Over Unlawful Drug Restrictions businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.
In Featured, News by Ged Kenslea
December 21, 2020
Amgen joined eight other rogue drug companies by
declaring last week that it will refuse to sell ‘orphan drugs’ (expensive drugs for rare diseases) at the legally required ‘340B price’
as required by section 340B of the U.S. Public Health Services Act
Refusals are tone-deaf moves by obscenely wealthy drug companies during height of coronavirus pandemic
WASHINGTON (December 21, 2020) AIDS Healthcare Foundation (AHF) will host a socially distant protest and car caravan targeting Amgen for its announced refusal to sell so-called “orphan drugs’ at reduced prices to nonprofit providers who are covered entities under the 340B Drug Discount Program. The protest will take place Tuesday, December 22 from 11am to 12noon at Amgen’s corporate headquarters (1100 Rancho Conejo Blvd, Thousand Oaks, CA 91320).